SCHEMBL742951

SCHEMBL742951

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(CN4CCC4)cc3)n[nH]c2s1)c1ccc(F)cc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.62
BCR P11274 2/20 0.62
AURKA O14965 1/20 0.45
CYP2C9 P11712 1/20 0.45
MCHR1 Q99705 3/20 0.41
HTR2C P28335 2/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ACKR3 P25106 5/20 0.40
KDR P35968 1/20 0.40
NTRK1 P04629 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.39
EPAS1 Q99814 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL742130 0.98 ABL1 (0.64) ABL1BCRAURKACYP2C9MCHR1
SCHEMBL742456 0.98 ABL1 (0.65) ABL1BCRAURKACYP2C9MCHR1
SCHEMBL739685 0.93 ABL1 (0.56) ABL1BCRAURKACYP2C9NPC1
SCHEMBL740623 0.93 ABL1 (0.72) ABL1BCRAURKACYP2C9RAB9A
SCHEMBL741731 0.92 ABL1 (0.61) ABL1BCRAURKACYP2C9NPC1
SCHEMBL742638 0.91 ABL1 (0.74) ABL1BCRAURKACYP2C9MCHR1
SCHEMBL740581 0.91 ABL1 (0.63) ABL1BCRAURKACYP2C9NPC1
SCHEMBL743418 0.91 ABL1 (0.60) ABL1BCRAURKACYP2C9MCHR1
SCHEMBL741183 0.90 ABL1 (0.76) ABL1BCRAURKACYP2C9RAB9A
SCHEMBL740752 0.90 ABL1 (0.76) ABL1BCRAURKACYP2C9RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed